Premia Global Advisors’s Eli Lilly LLY Stock Holding History

Premia Global Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-65	Closed	-$8K	–	233
2019 Q1	$8K	Buy	+65	New	+$7.9K	0.01%	347

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Premia Global Advisors's LLY Position: Q2 2019 in Review

Premia Global Advisors sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 65 shares — an estimated $8K sold.

Premia Global Advisors first reported a position in LLY in Q1 2019 and held it in 1 quarter. The position peaked at $8K in Q1 2019. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

Premia Global Advisors reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
Premia Global Advisors sold 65 Eli Lilly shares in Q2 2019, an estimated $8K.
Premia Global Advisors first reported a position in Eli Lilly in Q1 2019 and held it in 1 quarter.
Premia Global Advisors's Eli Lilly position peaked at $8K in Q1 2019.
1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on Premia Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.